Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2018

  • ID: 4516413
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Gastro-Intestinal Stromal Tumors market. It covers emerging therapies for Gastro-Intestinal Stromal Tumors in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Gastro-Intestinal Stromal Tumors pipeline products by the company.

Short-term Launch Highlights:
Find out which Gastro-Intestinal Stromal Tumors pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Gastro-Intestinal Stromal Tumors phase 3 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 2 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors phase 1 clinical trial pipeline products
  • Gastro-Intestinal Stromal Tumors preclinical research pipeline products
  • Gastro-Intestinal Stromal Tumors discovery stage pipeline products
  • Gastro-Intestinal Stromal Tumors pipeline products short-term launch highlights
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Gastro-Intestinal Stromal Tumors Pipeline by Stages
2. Gastro-Intestinal Stromal Tumors Pipeline by Drug Class
3. Gastro-Intestinal Stromal Tumors Pipeline by Company
4. Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trial Insights
5. Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trial Insights
6. Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trial Insights
7. Gastro-Intestinal Stromal Tumors Preclinical Research Insights
8. Gastro-Intestinal Stromal Tumors Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trials, 2018
Table 2: Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trials, 2018
Table 3: Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trials, 2018
Table 4: Gastro-Intestinal Stromal Tumors Preclinical Research, 2018
Table 5: Gastro-Intestinal Stromal Tumors Discovery Stage, 2018

List of Figures
Figures 1: Gastro-Intestinal Stromal Tumors Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Gastro-Intestinal Stromal Tumors Pipeline Molecules by Drug Class, 2018
Figure 3: Gastro-Intestinal Stromal Tumors Pipeline Molecules by Company, 2018
Figure 4: Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trial Highlights, 2018
Figure 5: Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trial Highlights, 2018
Figure 6: Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trial Highlights, 2018
Figure 7: Gastro-Intestinal Stromal Tumors Preclinical Research Highlights, 2018
Figure 8: Gastro-Intestinal Stromal Tumors Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll